ArticleOncology letters2016

Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway.

Qin-Fang Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.